Change in clinical status, social functioning, weight and sexual adverse events over the first 6 months of treatment: pan-european results from the schizophrenia outpatient health outcomes (SOHO) study

被引：0
|
作者：
V Mavreas
D Novick
S Tzivelekis
M Ratcliffe
机构：
[1] University of Ioannina,
[2] Eli Lilly and Company,undefined
[3] the SOHO Study Group,undefined
来源：
Annals of General Hospital Psychiatry | / 2卷 / Suppl 1期
关键词：
Clozapine; Risperidone; Olanzapine; Social Functioning; Quetiapine;
D O I：
10.1186/1475-2832-2-S1-S144
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 38 条
  • [1] Clinical and functional status, weight and sexual adverse events over the first six months of treatment: Greek results from the schizophrenia outpatient health outcomes (SOHO) study
    V Mavreas
    C Touloumis
    D Novick
    S Tzivelekis
    Annals of General Hospital Psychiatry, 2 (Suppl 1):
  • [2] Change in clinical status and functioning over the first three months of treatment: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Edgell, ET
    Frewer, P
    Haro, JM
    Wright, P
    JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (03) : A19 - A19
  • [3] Clinical status and functioning after the first six months of treatment: Results from the schizophrenia outpatient health outcomes (SOHO) study
    Jones, PB
    Edgell, ET
    Haro, JM
    Novick, D
    Tzivelekis, S
    Frewer, P
    JOURNAL OF PSYCHOPHARMACOLOGY, 2003, 17 (03) : A51 - A51
  • [4] Clinical and functional status over the first three months of treatment: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Edgell, ET
    Haro, JM
    Frewer, P
    Wright, P
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 282 - 282
  • [5] Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study
    Haro, JM
    Edgell, ET
    Novick, D
    Alonso, J
    Kennedy, L
    Jones, PB
    Ratcliffe, M
    Breier, A
    ACTA PSYCHIATRICA SCANDINAVICA, 2005, 111 (03) : 220 - 231
  • [6] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the pan-European SOHO (schizophrenia outpatient health outcomes) study
    Haro, J
    Novick, D
    Belger, M
    Tzivelekis, S
    Murray, D
    Texeira, JM
    Alonso, J
    Bousono, MG
    Gasquet, I
    Kristensen, H
    Jones, PB
    Croudace, T
    Knapp, M
    Lepine, JP
    Mavreas, V
    Naber, D
    Pancheri, P
    Slooff, CJ
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 486 - 486
  • [7] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the Pan-European SOHO (schizophrenia outpatient health outcomes) study
    Novick, D
    BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 71S - 71S
  • [8] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia. 24-month results from the Pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
    Haro, JM
    Novick, D
    Belger, M
    Tzivelekis, S
    Bushe, C
    Murray, D
    Texeira, JM
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A10 - A10
  • [9] Baseline results from the Schizophrenia Outpatient Health Outcomes study (SOHO): A 3-year, pan-European, observational health outcomes study in schizophrenia
    Haro, JM
    Edgell, ET
    Frewer, P
    Novick, D
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 265 - 265
  • [10] Quality of life and health status of previously untreated schizophrenic patients over the first 6 months of treatment: Results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
    Gasquet, I
    Haro, JM
    Novick, D
    Frewer, R
    Tzivelekis, S
    Tcherny-Lessenot, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S346 - S347
1234